Wolfe Research initiated coverage of Pfizer (PFE) with an Underperform rating and $25 price target
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Notable open interest changes for November 13th
- Pfizer Considers Selling Hospital Unit to Free Up Cash and Reduce Debt
- NVAX Earnings: Novavax Stock Down on Weak 2024 Revenue Outlook
- Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
- Pfizer said to be exploring sale of hospital drugs unit, Reuters reports